Navigating the “MACE” in Cardiovascular Outcomes Trials and Decoding the Relevance of Atherosclerotic CVD Benefits Versus Heart Failure Benefits
Diabetes, Obesity and Metabolism - United Kingdom
doi 10.1111/dom.13740
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2019
Authors
Publisher
Wiley